Share This Page
Drug Price Trends for FLUTICASONE-SALMETEROL
✉ Email this page to a colleague
Average Pharmacy Cost for FLUTICASONE-SALMETEROL
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FLUTICASONE-SALMETEROL 55-14 | 00093-3607-82 | 107.73504 | EACH | 2025-04-23 |
| FLUTICASONE-SALMETEROL 100-50 | 00054-0326-56 | 1.19012 | EACH | 2025-04-23 |
| FLUTICASONE-SALMETEROL 100-50 | 00093-7517-31 | 1.19012 | EACH | 2025-04-23 |
| FLUTICASONE-SALMETEROL 113-14 | 00093-3608-82 | 103.74480 | EACH | 2025-04-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Fluticasone-Salmeterol Market Analysis and Price Projections
Introduction to Fluticasone-Salmeterol
Fluticasone-salmeterol is a combination drug used primarily for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It combines fluticasone propionate, a corticosteroid, and salmeterol, a long-acting beta2-adrenergic receptor agonist (LABA). This combination is known for its effectiveness in reducing symptoms such as shortness of breath, coughing, and chest tightness.
Market Overview
The global market for fluticasone-salmeterol is expected to experience significant growth over the coming years. Here are some key points:
- Market Size and Growth: The salmeterol market, which includes fluticasone-salmeterol combinations, is projected to reach $615 million by 2027, growing at a Compound Annual Growth Rate (CAGR) of 3.82% from 2022 to 2027[3].
- Geographical Dominance: North America currently holds a dominant market share, primarily due to the ready availability of the drug, high medical literacy, and substantial healthcare budgets. However, the Asia-Pacific region is expected to offer lucrative growth opportunities due to increasing pollution levels and a growing pharmaceutical sector[3].
Key Drivers of Market Growth
Several factors are driving the growth of the fluticasone-salmeterol market:
- Increasing Prevalence of Respiratory Diseases: The rise in cases of asthma and COPD is a significant driver. These conditions are becoming more common due to deteriorating environmental factors such as air pollution[3].
- Long-Lasting Efficacy: Salmeterol's 12-hour duration of action makes it more valuable than short-acting beta2-agonists like albuterol, which has a 4- to 6-hour duration[1].
- Cost-Effectiveness: Despite some side effects, the long-term cost-effectiveness of fluticasone-salmeterol combinations makes them a preferred choice for managing chronic respiratory conditions[4].
Market Segmentation
The market can be segmented in several ways:
- By Application: The primary applications include asthma, bronchospasm, and COPD. The demand for fluticasone-salmeterol is highest in the asthma segment due to its efficacy in controlling symptoms[3].
- By Distribution Channel: The market is divided into offline and online distribution channels. Online channels are gaining traction due to price sensitivity and convenience, with vendors offering discounts and care plans that reduce costs for consumers[3].
Price Projections and Cost Analysis
The prices of fluticasone-salmeterol vary based on the formulation and dosage:
- Inhalation Aerosol: Prices range from $325.94 for a 45 mcg-21 mcg formulation to $526.60 for a 230 mcg-21 mcg formulation for a 12-gram supply[2].
- Inhalation Powder: Prices range from $103.83 for a 100 mcg-50 mcg formulation to $163.65 for a 500 mcg-50 mcg formulation for a 60-powder supply[2].
Brand Names and Generic Options
Several brand names are available for fluticasone-salmeterol combinations, including:
- Advair Diskus
- Wixela Inhub
- Advair HFA
- AirDuo Respiclick
Generic options are also available, which can be more cost-effective for patients[2].
Challenges and Restraints
Despite the growth prospects, the market faces some challenges:
- Side Effects: Salmeterol can cause side effects such as dizziness, sinus infections, migraine headaches, and breathing problems, which can restrain market growth[1].
- Regulatory Scrutiny: The use of LABAs like salmeterol is under regulatory scrutiny due to potential risks, which can impact market dynamics[3].
Key Players and Competitive Landscape
The market is highly competitive with several key players:
- GlaxoSmithKline
- Lupin Limited
- MidasCare
- Teva Pharmaceutical Industries
- Intas Pharmaceuticals
These companies compete based on factors such as price, user-friendly interface, value-added benefits, and service benefits. To gain a competitive edge, vendors are focusing on developing new technologies and integrating them into their product portfolios[1].
Regional Outlook
- North America: Currently holds the largest market share due to high medical literacy and significant healthcare budgets.
- Asia-Pacific: Expected to offer significant growth opportunities due to increasing pollution levels and growing pharmaceutical investments[3].
Consumer Behavior and Price Sensitivity
Consumers are highly price-sensitive, and the availability of discounts and care plans through online channels is influencing purchasing decisions. For example, online medical support sites can offer the same drugs at lower prices compared to offline pharmacies[3].
Key Takeaways
- The fluticasone-salmeterol market is driven by the increasing prevalence of respiratory diseases and the long-lasting efficacy of the drug.
- North America dominates the market, but Asia-Pacific is expected to grow significantly.
- Price sensitivity and the availability of online discounts are key factors influencing consumer behavior.
- Despite growth prospects, the market faces challenges from side effects and regulatory scrutiny.
FAQs
1. What are the primary applications of fluticasone-salmeterol?
- The primary applications include asthma, bronchospasm, and COPD.
2. Which region currently dominates the fluticasone-salmeterol market?
- North America currently holds the dominant market share.
3. What are the key drivers of the fluticasone-salmeterol market?
- The increasing prevalence of respiratory diseases and the long-lasting efficacy of the drug are key drivers.
4. How does the price of fluticasone-salmeterol vary?
- Prices vary based on the formulation and dosage, ranging from approximately $100 to over $500 for different inhalation aerosol and powder formulations.
5. What are some of the side effects associated with salmeterol?
- Side effects include dizziness, sinus infections, migraine headaches, and breathing problems.
Sources:
- OpenPR: Salmeterol Market Growth Set to Surge Significantly till 2025
- Drugs.com: Fluticasone/salmeterol Prices, Coupons, Copay Cards & Patient Assistance
- IndustryARC: Salmeterol Market Share, Size and Industry Growth Analysis 2022
- Resmed Journal: Cost-effectiveness of fluticasone propionate/salmeterol (500/50 μg) in patients with chronic obstructive pulmonary disease[4].
More… ↓
